» Articles » PMID: 1284235

Diagnostic Value of Analysis of Cystatin C and Protein HC in Biological Fluids

Overview
Journal Clin Nephrol
Specialty Nephrology
Date 1992 Jan 1
PMID 1284235
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Cystatin C, a 13 kDa-protein, is produced by most nucleated cells and is catabolized by the renal tubular cells after passing the glomerular filter. It belongs to the family 2 of the cystatin superfamily of proteins. The function of cystatin C is to regulate the activity of cysteine proteinases and cystatin C seems to be the main cysteine proteinase inhibitor of most investigated human biological fluids. Its normal level in plasma is 0.8-2.5 mg/l, in cerebrospinal fluid 4-14 mg/l and in urine 0.03-0.3 mg/l. The production rate of cystatin C is remarkably constant and its plasma concentration can therefore be used as a reliable measure of the glomerular filtration rate (GFR). Indeed, the cystatin C plasma concentration is more closely correlated to the GFR than the plasma levels of creatinine and all other investigated low molecular weight proteins, including beta 2-microglobulin and retinol binding protein. Protein HC, alias alpha 1-microglobulin, is produced by the liver as a 27 kDa-glycoprotein. It belongs to the lipocalin superfamily of hydrophobic ligand binding proteins and more than 50% of the normal plasma amount of protein HC is present as a high molecular weight HC-IgA complex carrying antibody activity. The plasma concentration of free protein HC is, in contrast to that of HC-IgA, mainly determined by the GFR. The normal values for the plasma concentrations of HC-IgA and free protein HC are 36-620 mg/l and 14-26 mg/l, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Emerging trends in the cystatin C sensing technologies: towards better chronic kidney disease management.

Raveendran J, Gangadharan D, Bayry J, Rasheed P RSC Adv. 2025; 15(7):4926-4944.

PMID: 39957820 PMC: 11826153. DOI: 10.1039/d4ra07197b.


Pseudo acute kidney injury in patients receiving CDK4/6 inhibitors.

Buijs S, Jongbloed E, van Bergen L, Ramakers C, Koolen S, Mathijssen R Br J Cancer. 2025; .

PMID: 39930149 DOI: 10.1038/s41416-025-02951-4.


The Human Phospholipase B-II Precursor (HPLBII-P) in Urine as a Novel Biomarker of Glomerular Activity in COVID-19 and Diabetes Mellitus.

Xu S, Hultstrom M, Larsson A, Lipcsey M, Lindskog C, Bulow S J Clin Med. 2024; 13(9).

PMID: 38731071 PMC: 11084804. DOI: 10.3390/jcm13092540.


Cystatin C Attenuates Perihematomal Secondary Brain Injury by Inhibiting the Cathepsin B/NLRP3 Signaling Pathway in a Rat Model of Intracerebral Hemorrhage.

Zhou Y, Dong W, Wang L, Ren S, Wei W, Wu G Mol Neurobiol. 2024; 61(11):9646-9662.

PMID: 38676809 DOI: 10.1007/s12035-024-04195-4.


Effect of Two Cystatin C Reagents and Four Equations on Glomerular Filtration Rate Estimations After Standardization.

Lee H, Bae G, Lee J, Park H Ann Lab Med. 2023; 43(6):565-573.

PMID: 37387489 PMC: 10345172. DOI: 10.3343/alm.2023.43.6.565.